Fundraising Fox

SAGA Diagnostics

Research Triangle Park, US · Founded 2016 · 91 employees on LinkedIn · 5 known investors

SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages. The company serves oncology and treatment decision-making in the healthcare sector.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Founders & leadership

RBRoopom Banerjee
Roopom BanerjeeinExecutive Chairman

Investors · 5

FSGLund · $1.1M – $6.5M
Hadean VenturesOslo
LU InnovationLund
Scietyreported · 2 sourcesStockholm

Also in the syndicate · 1

Segulah Medical Accelerationlead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Danish Velatir gets €5 million seed as companies seek greater control over AI use - ArcticStartuparcticstartup.com · Aug 2026Swedish startup Millow raises €2 million to scale low-water mycelium protein - ArcticStartuparcticstartup.com · Aug 2026Deeptech elite is heading to Espoo: NORDEEP 2026 lineup revealed - ArcticStartuparcticstartup.com · Aug 2026Sweden's SAGA Diagnostics set for acquisition as Roche builds out MRD infrastructure - ArcticStartuparcticstartup.com · Apr 2026SAGA Diagnostics raises €10.5 million - Hadean Ventureshadeanventures.com · Jun 2021

Frequently asked questions

What does SAGA Diagnostics do?
SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages. The company serves oncology and treatment decision-making in the healthcare sector.
Who are SAGA Diagnostics's investors?
SAGA Diagnostics's investors include FSG, Hadean Ventures, LU Innovation, Sciety.
Where is SAGA Diagnostics headquartered?
SAGA Diagnostics is headquartered in Research Triangle Park, US.